Novasenta’s discovery process is patient-centric with a focus on in-depth analysis of high-quality samples from human tissues. We comprehensively map the tissue microenvironment and capitalize on the convergence of biology and computation to discover novel, therapeutically relevant targets.

Our Science – A Unique Approach to Target Discovery

Driven by the diverse perspectives of our team, Novasenta has built a unique and dynamic target discovery and validation platform. Our proprietary approach will accelerate the discovery of novel, druggable targets and the development of the next generation of safe and effective immune-mediated and cancer therapeutics.

Through our proprietary computational data mining platform, we interrogate these data to extract relevant biological insights, characterize transcriptionally distinct cell subtypes and states in the tissue microenvironment, and identify the immune networks in which they function. This approach enables Novasenta to identify novel targets across all immune cells and explore how their role in immune networks can shape the disease response.

Our Pipeline

Through scaling of in-house functional assays for antibody screening and selection, Novasenta is rapidly advancing a pipeline of therapeutics against novel immune cell targets discovered by our team of computational and experimental biologists. We believe these programs represent the next generation of drug candidates, ones that extend hope to patients that there will be safer and more effective immune-mediated and cancer therapies to come.